PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Solent Automation specialises in developing, deploying and supporting automation robots to perform and tackle common manual labour-intensive tasks in factories. To solve the 'pick-and-place' challenges in an industrial setup, these robots are created with proven reliable components coupled with proprietary software to solve 'pick-and-place' challenges in an industrial environment. Two of the company's noteworthy products are 'SOLPAL 8' and 'SOLPACK 1XP, both are equipped with an all-in-one gripping tool, and can handle 16 boxes per minute and 60 packs per minute, respectively. Backed by a team of experts from manufacturing and robotics, Solent Automation provides on-site installation, training, and remote support for its products. There is also a rent-to-buy option through a 3rd party finance company. With the investment, the company aims at providing more robotic equipment most needed in factories focused on labour-intensive work functions.
days to go:
Expired
investment:
£76,000
Richard Brendon is a prominent British design brand that values master craftspeople by creating a platform for contemporary and timeless tableware collections that challenge the expected. It has received extensive media coverage since 2013 including the FT and NY Times. The company has sold to more than 120 B2B customers in 15 countries. It has seen a growth of 75% since 2015 amounting to £2.5m sales to date and more than 3,000 orders delivered. Richard now plans to take his brand global. It has enjoyed a CAGR of 75% from 2015 to 2019, with revenue of £1.12m in 2019. The company plans on opening up new markets, creating four additional collections over the coming years to develop existing channels and territories.
days to go:
Expired
investment:
£250,350
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
A rapidly growing printing, merchandising and clothing brand with customers including Google, Amazon and Nike. Awesome Merchandise produce all their products in-house and ship internationally. The company has created over 65 million items for more than 70,000 customers and have been in profit every year. Investment will help to build a new factory based in Austin, TX, USA and to create US and European websites.
days to go:
Expired
investment:
£654,870
Thread Tales is a luxury sustainable fashion brand that designs sustainable scarves, blankets, kaftans and travel wraps. Its designs are unique and hand-woven by Artisans. The company's products are featured in the Conduit, at Soho Farmhouse, and Harvey Nichols. It has regularly participated in many pop-events in Tier One locations like Le Pigalle Hotel, Paris and Grace Belgravia, London. Thread Tales has influencer endorsements from Sirens and Seaplanes, Eva Ciland, Sustainably Chic, and Sabine Turner. With the proceeds, the company will develop bespoke pieces for this market. It also has an exciting potential partnership with a huge luxury hotel chain.
days to go:
Expired
investment:
£79,293
Having a successful track record of building a business in the travel sector, the founder of Private Traveller, Mr. Peter Williams is sure to grow his company in the global luxury travel market which is expected to generate $1,154 billion by 2022. Founded in 2016, Private Traveller is a luxury tour operator (ATOL bonded) that aims to provide high-end holiday packages to its discerning clientele. To achieve such high-level of service standards, Private Traveller has commercial contracts in place with 17 destination management companies, 275 hotels and agreements with two air carriers.
days to go:
Expired
investment:
£65,300
